arrow
A

Anke Unger

lead discovery center gmbh
H指数:16
被引数:1,401

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Design, Synthesis, and Structural Evolution of Pseudo-Natural Product IDO1 Inhibitors and Degraders

设计、合成及结构演化的伪天然产物IDO1抑制剂与降解剂的研制

2025-11-270
OAAI
Highly potent quinoxalinediones inhibit a-hemolysin and ameliorate Staphylococcus aureus lung infections

高活性的喹喔啉二酮类化合物能够抑制α-溶血素并改善金黄色葡萄球菌肺部感染

2025-04-011
OAAI
Discovery of tetrazolo-pyridazine-based small molecules as inhibitors of MACC1-driven cancer metastasis

基于四唑哒嗪的小分子作为MACC1-driven肿瘤转移抑制剂的发现

2023-12-013
OAAI
Protection of pancreatic islets from oxidative cell death by a peripherally-active morphinan with increased drug safety

通过具有外周活性的吗啡喃保护胰岛免受氧化细胞死亡,并增加药物安全性

2023-09-011
OAAI
Novel tetrazolopyridazine based MACC1 transcriptional inhibitors as promising anti-metastatic therapy

基于四唑哒嗪的新型MACC1转录抑制剂作为有希望的抗转移治疗

2023-01-150
PRE
Targeting Her2-insYVMA with Covalent Inhibitors-A Focused Compound Screening and Structure-Based Design Approach
2020-09-1513
PREAI
Preclinical Efficacy of Covalent-Allosteric AKT Inhibitor Borussertib in Combination with Trametinib in KRAS-Mutant Pancreatic and Colorectal Cancer
2019-05-0167
PREAI
Inhibition of osimertinib-resistant epidermal growth factor receptor EGFR-T790M/C797S
2019-01-0135
OAAI